Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 219747Generated: October 27, 2026

Lithium Hydroxide → 2-tert-Butyl-4-{4-[3-(4-methyl-4H-[1,2,4]triazol-3-ylsulfanyl)-propyl]-piperazin-1-yl}-6-cyclobutylpyrimidine

https://huagongshe.com/reaction/219747

Reaction equation

Participants

RoleNameHCIDCharge
ReactantLithium HydroxideHCID 3939—
ReactantPotassium IodideHCID 4875—
Reactant2-tert-Butyl-4-[4-(3-chloro-propyl)-piperazin-1-yl]-6-cyclobutyl-pyrimidineHCID 66673104—
ReactantHCID 178481306HCID 178481306—
SolventDimethylformamideHCID 6228—
Product2-tert-Butyl-4-{4-[3-(4-methyl-4H-[1,2,4]triazol-3-ylsulfanyl)-propyl]-piperazin-1-yl}-6-cyclobutylpyrimidineHCID 1156815447%

Reaction Steps

0.8 g of 2-tert-Butyl-4-[4-(3-chloro-propyl)-piperazin-1-yl]-6-cyclobutyl-pyrimidine (2.28 mmol), 0.29 g of 4-methyl-3-mercapto-1,2,4-triazole (2.52 mmol), 0.15 g of lithium hydroxide and a tip of a spatula of potassium iodide were dissolved in 20 ml of dimethylformamide. The mixture was stirred for 14 h at room temperature and then extracted with water and ethyl acetate. The organic layer was dried over magnesium sulfate, filtered, and evaporated to dryness. The residue was then purified by column chromatography on silica gel (dichloromethane-methanol (2-10%)) to yield an oily residue that was precipitated with acetonitrile thereby yielding 0.46 g of the title compound (47%).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08202868B2
Source datasetuspto-grants-2012_06
ORD IDord-02dd9ebd37574f9fb31f0a290af4abce
Source noteuspto-grants-2012_06